1,925
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

A review of mammalian in vivo genotoxicity of hexavalent chromium: implications for oral carcinogenicity risk assessment

ORCID Icon, , , &
Pages 820-849 | Received 05 Jul 2021, Accepted 22 Oct 2021, Published online: 21 Jan 2022

References

  • Aoki Y, Matsumoto M, Matsumoto M, Masumura K, Nohmi T. 2019. Mutant frequency is not increased in mice orally exposed to sodium dichromate. Food Saf (Tokyo)). 7(1):2–10.
  • Bagchi D, Hassoun EA, Bagchi M, Muldoon DF, Stohs SJ. 1995. Oxidative stress induced by chronic administration of sodium dichromate [Cr(VI)] to rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 110(3):281–287.
  • Bagchi D, Hassoun EA, Bagchi M, Stohs SJ. 1995. Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 110(2):177–187.
  • Bagchi D, Vuchetich PJ, Bagchi M, Hassoun EA, Tran MX, Tang L, Stohs SJ. 1997. Induction of oxidative stress by chronic administration of sodium dichromate [chromium VI] and cadmium chloride [cadmium II] to rats. Free Radic Biol Med. 22(3):471–478.
  • Balansky RM, D'Agostini F, Izzotti A, De Flora S. 2000. Less than additive interaction between cigarette smoke and chromium(VI) in inducing clastogenic damage in rodents. Carcinogenesis. 21:1677–1682.
  • Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. 2009. Crypt stem cells as the cells-of-origin of intestinal cancer [Research Support, Non-U.S. Gov't]. Nature. 457(7229):608–611.
  • Bhat VS, Cohen SM, Gordon EB, Wood CE, Cullen JM, Harris MA, Proctor DM, Thompson CM. 2020. An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet. Crit Rev Toxicol. 50(8):685–706.
  • Chandra SA, Nolan MW, Malarkey DE. 2010. Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays. Toxicol Pathol. 38(1):188–197.
  • Cheng L, Liu S, Dixon K. 1998. Analysis of repair and mutagenesis of chromium-induced DNA damage in yeast, mammalian cells, and transgenic mice. Environ Health Perspect. 106 Suppl 4(Suppl 4):1027–1032.
  • Cheng L, Sonntag DM, de Boer J, Dixon K. 2000. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice. J Environ Pathol Toxicol Oncol. 19(3):239–249.
  • Chidiac P, Goldberg MT. 1987. Lack of induction of nuclear aberrations by captan in mouse duodenum [Research Support, Non-U.S. Environ Mutagen. 9(3):297–306.
  • Cullen JM, Ward JM, Thompson CM. 2016. Reevaluation and classification of duodenal lesions in B6C3F1 mice and F344 rats from 4 studies of hexavalent chromium in drinking water. Toxicol Pathol. 44(2):279–289.
  • Dana Devi K, Rozati R, Saleha Banu B, Jamil K, Grover P. 2001. In vivo genotoxic effect of potassium dichromate in mice leukocytes using comet assay. Food Chem Toxicol. 39(8):859–865.
  • De Flora S, D'Agostini F, Balansky R, Micale R, Baluce B, Izzotti A. 2008. Lack of genotoxic effects in hematopoietic and gastrointestinal cells of mice receiving chromium(VI) with the drinking water. Mutat Res. 659(1-2):60–67.
  • De Flora S, Iltcheva M, Balansky RM. 2006. Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses. Mutat Res. 610(1-2):38–47.
  • den Braver-Sewradj SP, van Benthem J, Staal YCM, Ezendam J, Piersma AH, Hessel EVS. 2021. Occupational exposure to hexavalent chromium. Part II. Hazard assessment of carcinogenic effects. Regul Toxicol Pharmacol. 126:105045.
  • Eastmond DA. 2012. Factors influencing mutagenic mode of action determinations of regulatory and advisory agencies. Mutat Res. 751(1):49–63.
  • EFSA. 2017. Clarification of some aspects related to genotoxicity assessment. Efsa J. 15(12):5113.
  • Elshazly MO, Morgan AM, Ali ME, Abdel-Mawla E, Abd El-Rahman SS. 2016. The mitigative effect of Raphanus sativus oil on chromium-induced geno- and hepatotoxicity in male rats. J Adv Res. 7(3):413–421.
  • EPL. 2013. Quantitative histopathologic evaluations of mouse duodenum specimens. Sterling, VA. 928-002 and 928-003.
  • Fedala A, Adjroud O, Abid-Essefi S, Timoumi R. 2021. Protective effects of selenium and zinc against potassium dichromate-induced thyroid disruption, oxidative stress, and DNA damage in pregnant Wistar rats. Environ Sci Pollut Res Int. 28(18):22563–22576.
  • Feng Y, Bommer GT, Zhao J, Green M, Sands E, Zhai Y, Brown K, Burberry A, Cho KR, Fearon ER. 2011. Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. Gastroenterology. 141(3):1003–1013. e1001-1010.
  • FSCJ. 2019. Risk Assessment Report Hexavalent Chromium (Beverages). Food Safety Commission of Japan. 7(2):56–57.
  • Garcia-Rodriguez MC, Carvente-Juarez MM, Altamirano-Lozano MA. 2013. Antigenotoxic and apoptotic activity of green tea polyphenol extracts on hexavalent chromium-induced DNA damage in peripheral blood of CD-1 mice: analysis with differential acridine orange/ethidium bromide staining. Oxid Med Cell Longev. 2013:486419.
  • Garcia-Rodriguez MC, Montano-Rodriguez AR, Altamirano-Lozano MA. 2016. Modulation of hexavalent chromium-induced genotoxic damage in peripheral blood of mice by epigallocatechin-3-gallate (EGCG) and its relationship to the apoptotic activity. J Toxicol Environ Health A. 79(1):28–38.
  • Garcia-Rodriguez MDC, Serrano-Reyes G, Hernandez-Cortes LM, Altamirano-Lozano M. 2021. Antigenotoxic effects of (-)-epigallocatechin-3-gallate (EGCG) and its relationship with the endogenous antioxidant system, 8-hydroxydeoxyguanosine adduct repair (8-OHdG), and apoptosis in mice exposed to chromium(VI). J Toxicol Environ Health A. 84(8):331–344.
  • Gibb HJ, Lees PS, Pinsky PF, Rooney BC. 2000. Clinical findings of irritation among chromium chemical production workers. Am J Ind Med. 38(2):127–131.
  • Glaser U, Hochrainer D, Kloppel H, Oldiges H. 1986. Carcinogenicity of sodium dichromate and chromium (VI/III) oxide aerosols inhaled by male Wistar rats. Toxicology. 42(2-3):219–232. eng.
  • Goldberg MT, Blakey DH, Bruce WR. 1983. Comparison of the effects of 1,2-dimethylhydrazine and cyclophosphamide on micronucleus incidence in bone marrow and colon. Mutat Res. 109(1):91–98.
  • Goldberg MT, Chidiac P. 1986. An in vivo assay for small intestine genotoxicity. Mutat Res. 164(4):209–215.
  • Gollapudi BB, Johnson GE, Hernandez LG, Pottenger LH, Dearfield KL, Jeffrey AM, Julien E, Kim JH, Lovell DP, Macgregor JT, et al. 2013. Quantitative approaches for assessing dose-response relationships in genetic toxicology studies. Environ Mol Mutagen. 54(1):8–18.
  • Health Canada. 2016. Guidelines for Canadian drinking water quality: guideline technical document — chromium. In: Water and Air Quality Bureau HEaCSB, editor. Ottawa, Ontario.: Health Canada.
  • Howard BE, Phillips J, Miller K, Tandon A, Mav D, Shah MR, Holmgren S, Pelch KE, Walker V, Rooney AA, et al. 2016. SWIFT-Review: a text-mining workbench for systematic review. Syst Rev. 5:87.
  • IARC. 1990. Chromium, nickel and welding, IARC Monogr. Eval. Carcinog. Risks Hum. 49:1–648.
  • Itoh S, Shimada H. 1996. Micronucleus induction by chromium and selenium, and suppression by metallothionein inducer. Mutat Res. 367(4):233–236.
  • Itoh S, Shimada H. 1997. Clastogenicity and mutagenicity of hexavalent chromium in lacZ transgenic mice. Toxicol Lett. 91(3):229–233.
  • Itoh S, Shimada H. 1998. Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium. Mutat Res. 412(1):63–67.
  • Izzotti A, Bagnasco M, Camoirano A, Orlando M, De Flora S. 1998. DNA fragmentation, DNA-protein crosslinks, postlabeled nucleotidic modifications, and 8-hydroxy-2'-deoxyguanosine in the lung but not in the liver of rats receiving intratracheal instillations of chromium(VI). Chemoprevention by oral N-acetylcysteine. Mutat Res. 400:233–244.
  • Johnson GE, Soeteman-Hernandez LG, Gollapudi BB, Bodger OG, Dearfield KL, Heflich RH, Hixon JG, Lovell DP, MacGregor JT, Pottenger LH, et al. 2014. Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. Environ Mol Mutagen. 55(8):609–623.
  • Kirkland D, Levy DD, LeBaron MJ, Aardema MJ, Beevers C, Bhalli J, Douglas GR, Escobar PA, Farabaugh CS, Guerard M, et al. 2019. A comparison of transgenic rodent mutation and in vivo comet assay responses for 91 chemicals. Mutat Res Genet Toxicol Environ Mutagen. 839:21–35.
  • Kirkland D, Speit G. 2008. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. Mutat Res. 654(2):114–132.
  • Kirman CR, Hays SM, Aylward LL, Suh M, Harris MA, Thompson CM, Haws LC, Proctor DM. 2012. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium. Chem Biol Interact. 200(1):45–64.
  • Kirpnick-Sobol Z, Reliene R, Schiestl RH. 2006. Carcinogenic Cr(VI) and the nutritional supplement Cr(III) induce DNA deletions in yeast and mice. Cancer Res. 66(7):3480–3484.
  • Kirsch-Volders M, Bolognesi C, Ceppi M, Bruzzone M, Fenech M. 2020. Micronuclei, inflammation and auto-immune disease. Mutat Res Rev Mutat Res. 786:108335.
  • Knudsen I. 1980. The mammalian spot test and its use for the testing of potential carcinogenicity of welding fume particles and hexavalent chromium. Acta Pharmacol Toxicol (Copenh)). 47(1):66–70.
  • Kumar S, Budhwar R, Nigam A, Priya S. 2009. Cytoprotection against Cr(6+)-induced DNA damage by alpha-lipoic acid: implications in reducing occupational cancer risk. Mutagenesis. 24(6):495–500.
  • Lambert IB, Singer TM, Boucher SE, Douglas GR. 2005. Detailed review of transgenic rodent mutation assays. Mutat Res. 590(1-3):1–280.
  • Long P. 2012. Review of Carcinogenesis Study of Sodium Dichromate Dihydrate (CAS NO. 7789-12-0) in F344 rats (drinking water study). Anatomic Pathology Expert Report by Vet Path Services.
  • Luippold RS, Mundt KA, Austin RP, Liebig E, Panko J, Crump C, Crump K, Proctor D. 2003. Lung cancer mortality among chromate production workers [Research Support, Non-U.S. Gov't]. Occup Environ Med. 60(6):451–457.
  • MacGregor JT, Frotschl R, White PA, Crump KS, Eastmond DA, Fukushima S, Guerard M, Hayashi M, Soeteman-Hernandez LG, Johnson GE, et al. 2015. IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutat Res Genet Toxicol Environ Mutagen. 783:66–78.
  • Malling HV, Burkhart JG. 1989. Use of phi X174 as a shuttle vector for the study of in vivo mammalian mutagenesis. Mutat Res. 212(1):11–21.
  • McCarroll N, Keshava N, Chen J, Akerman G, Kligerman A, Rinde E. 2010. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI). Environ Mol Mutagen. 51(2):89–111.
  • Minigaliyeva IA, Katsnelson BA, Privalova LI, Gurvich VB, Panov VG, Varaksin AN, Makeyev OH, Sutunkova MP, Loginova NV, Kireyeva EP, et al. 2014. Toxicodynamic and toxicokinetic descriptors of combined chromium (VI) and nickel toxicity. Int J Toxicol. 33(6):498–505.
  • Minocherhomji S, Liu Y, He YD, Fielden MR. 2020. Biomarkers of genome instability in normal mammalian genomes following drug-induced replication stress. Environ Mol Mutagen. 61(8):770–785.
  • Mirsalis JC, Hamilton CM, O'Loughlin KG, Paustenbach DJ, Kerger BD, Patierno S. 1996. Chromium (VI) at plausible drinking water concentrations is not genotoxic in the in vivo bone marrow micronucleus or liver unscheduled DNA synthesis assays. Environ Mol Mutagen. 28(1):60–63.
  • Moffat I, Martinova N, Seidel C, Thompson CM. 2018. Hexavalent chromium in drinking water. Journal AWWA. 110(5):E22–E35.
  • Morita T, MacGregor JT, Hayashi M. 2011. Micronucleus assays in rodent tissues other than bone marrow [Research Support, Non-U.S. Gov't Review]. Mutagenesis. 26(1):223–230.
  • Mukherjee P, Sarkar D, Sharma A. 1997. Effects of dietary consumption of black tea infusion alone and in combination with known clastogens on mouse bone marrow chromosomes in vivo. Food Chem Toxicol. 35(7):657–661.
  • Newton MF, Lilly LJ. 1986. Tissue-specific clastogenic effects of chromium and selenium salts in vivo. Mutat Res. 169(1-2):61–69.
  • NTP. 2007. National Toxicology Program technical report on the toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice. NTP Toxicity Report Series Number 72, NIH Publication No 07-5964.
  • NTP. 2008. National Toxicology Program technical report on the toxicology and carcinogenesis studies of sodium dichromate dihydrate (CAS No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies), NTP TR 546. NIH Publication No 08-5887.
  • NTP. 2010. National Toxicology Program technical report on the toxicology and carcinogenesis studies of chromium picolinate monohydrate (CAS NO. 27882-76-4) in F344/N rats and B6C3F1 mice (feed studies). NIH Publication No 08-5897.
  • O'Brien TJ, Ceryak S, Patierno SR. 2003. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res. 533(1-2):3–36.
  • O'Brien TJ, Ding H, Suh M, Thompson CM, Parsons BL, Harris MA, Winkelman WA, Wolf JC, Hixon JG, Schwartz AM, et al. 2013. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water [Research Support, Non-U.S. Mutat Res. 754(1-2):15–21.
  • OECD. 1986. OECD Guideline Test No. 484: Genetic Toxicology: Mouse Spott Test (deleted April 2, 2014).
  • OECD. 2016a. Test Guideline No. 475 - Mammalian Bone Marrow Chromosomal Aberration Test.
  • OECD. 2016b. Test Guideline No. 489 - In Vivo Mammalian Alkaline Comet Assay.
  • OECD. 2020. Test Guideline No. 488, - Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays. OECD, Paris, France.
  • OEHHA. 2011. Final Technical Support Document on Public Health Goal for Hexavalent Chromium in Drinking Water. Pesticide and Environmental Toxicology Branch, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency.
  • Orabi SH, Shawky SM. 2020. Ameliorative effects of grape seed oil on chromium-induced nephrotoxicity and oxidative stress in rats. SVR. 57(3):123–131.
  • Parsons BL, Manjanath MB, Myers MB, McKim KL, Wang Y, Gollapudi BB, Moore N, Haber Lt, Moore MM. 2012. Induction of cII and K-Ras mutation in lung DNA of Big Blue mice exposed to ethylene oxide by inhalation,. 43rd Annual Meeting Environmental Mutagen Society; Bellevue, Washington.
  • Parsons BL, Marchant-Miros KE, Delongchamp RR, Verkler TL, Patterson TA, McKinzie PB, Kim LT. 2010. ACB-PCR quantification of K-RAS codon 12 GAT and GTT mutant fraction in colon tumor and non-tumor tissue. Cancer Invest. 28(4):364–375.
  • Parsons BL, Myers MB, Meng F, Wang Y, McKinzie PB. 2010. Oncomutations as biomarkers of cancer risk [Review. Environ Mol Mutagen. 51(8-9):836–850.
  • Patlolla AK, Barnes C, Yedjou C, Velma VR, Tchounwou PB. 2009. Oxidative stress, DNA damage, and antioxidant enzyme activity induced by hexavalent chromium in Sprague-Dawley rats. Environ Toxicol. 24(1):66–73.
  • Potten CS, Loeffler M. 1990. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt [Research Support, Non-U.S. Gov't Review]. Development. 110(4):1001–1020.
  • Reliene R, Bishop AJ, Aubrecht J, Schiestl RH. 2004. In vivo DNA deletion assay to detect environmental and genetic predisposition to cancer. Methods Mol Biol. 262:125–139.
  • Rizk P, Barker N. 2012. Gut stem cells in tissue renewal and disease: methods, markers, and myths. Wiley Interdiscip Rev Syst Biol Med. 4(5):475–496.
  • Sarkar D, Sharma A, Talukder G. 1993. Differential protection of chlorophyllin against clastogenic effects of chromium and chlordane in mouse bone marrow in vivo. Mutat Res. 301(1):33–38.
  • Sekihashi K, Sasaki T, Yamamoto A, Kawamura K, Ikka T, Tsuda S, Sasaki YF. 2001. A comparison of intraperitoneal and oral gavage administration in comet assay in mouse eight organs. Mutat Res. 493(1-2):39–54.
  • Shindo Y, Toyoda Y, Kawamura K, Kurebe M, Shimada H, Hattori C, Satake S. 1989. Micronucleus test with potassium chromate(VI) administered intraperitoneally and orally to mice. Mutat Res. 223(4):403–406.
  • Soeteman-Hernandez LG, Johnson GE, Slob W. 2016. Estimating the carcinogenic potency of chemicals from the in vivo micronucleus test. Mutagenesis. 31(3):347–358.
  • SSAB. 2020. Memorandum: T. Augspurger (Chair, Secretaries' Science Advisory Board) to S. Holman (NC Department of Environmental Quality), Secretaries' Science Advisory Board response to inquiry on hexavalent chromium.
  • Stern AH. 2010. A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure. Environ Res. 110(8):798–807.
  • Stout MD, Herbert RA, Kissling GE, Collins BJ, Travlos GS, Witt KL, Melnick RL, Abdo KM, Malarkey DE, Hooth MJ. 2009. Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure. Environ Health Perspect. 117(5):716–722.
  • Stout MD, Nyska A, Collins BJ, Witt KL, Kissling GE, Malarkey DE, Hooth MJ. 2009. Chronic toxicity and carcinogenicity studies of chromium picolinate monohydrate administered in feed to F344/N rats and B6C3F1 mice for 2 years. Food Chem Toxicol. 47(4):729–733.
  • Suh M, Thompson CM, Kirman CR, Carakostas MC, Haws LC, Harris MA, Proctor DM. 2014. High concentrations of hexavalent chromium in drinking water alter iron homeostasis in F344 rats and B6C3F1 mice [Research Support, Non-U.S. Gov't]. Food Chem Toxicol. 65:381–388.
  • TCEQ 2016. Hexavalent Chromium Oral Reference Dose: Development Support Document (Final).
  • Thompson CM, Bichteler A, Rager JE, Suh M, Proctor DM, Haws LC, Harris MA. 2016. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: case study with hexavalent chromium. Mutat Res Genet Toxicol Environ Mutagen. 800-801:28–34.
  • Thompson CM, Haws LC, Harris MA, Gatto NM, Proctor DM. 2011. Application of the U.S. EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium [Research Support, Non-U.S. Gov't Review]. Toxicol Sci. 119(1):20–40.
  • Thompson CM, Kirman CR, Hays SM, Suh M, Harvey SE, Proctor DM, Rager JE, Haws LC, Harris MA. 2018. Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin-of-exposure values for hexavalent chromium. J Appl Toxicol. 38(3):351–365.
  • Thompson CM, Proctor DM, Haws LC, Hebert CD, Grimes SD, Shertzer HG, Kopec AK, Hixon JG, Zacharewski TR, Harris MA. 2011. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium [Research Support, Non-U.S. Gov't]. Toxicol Sci. 123(1):58–70.
  • Thompson CM, Proctor DM, Suh M, Haws LC, Hebert CD, Mann JF, Shertzer HG, Hixon JG, Harris MA. 2012. Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action [Research Support, Non-U.S. Gov't]. Toxicol Sci. 125(1):79–90.
  • Thompson CM, Proctor DM, Suh M, Haws LC, Kirman CR, Harris MA. 2013. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans. Crit Rev Toxicol. 43(3):244–274.
  • Thompson CM, Rager JE, Suh M, Ring CL, Proctor DM, Haws LC, Fry RC, Harris MA. 2016. Transcriptomic responses in the oral cavity of F344 rats and B6C3F1 mice following exposure to Cr(VI): implications for risk assessment. Environ Mol Mutagen. 57(9):706–716.
  • Thompson CM, Seiter J, Chappell MA, Tappero RV, Proctor DM, Suh M, Wolf JC, Haws LC, Vitale R, Mittal L, et al. 2015. Synchrotron-Based Imaging of Chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water . Toxicol Sci. 143(1):16–25.
  • Thompson CM, Suh M, Proctor DM, Haws LC, Harris MA. 2017. Ten factors for considering the mode of action of Cr(VI)-induced gastrointestinal tumors in rodents. Mutat Res Genet Toxicol Environ Mutagen. 823:45–57.
  • Thompson CM, Wolf JC, Elbekai RH, Paranjpe MG, Seiter JM, Chappell MA, Tappero RV, Suh M, Proctor DM, Bichteler A, et al. 2015. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy . Mutat Res Genet Toxicol Environ Mutagen. 789-790:61–66.
  • Thompson CM, Young RR, Dinesdurage H, Suh M, Harris MA, Rohr AC, Proctor DM. 2017. Assessment of the mutagenic potential of hexavalent chromium in the duodenum of big blue® rats. Toxicol Appl Pharmacol. 330:48–52.
  • Thompson CM, Young RR, Suh M, Dinesdurage HR, Elbekai RH, Harris MA, Rohr AC, Proctor DM. 2015. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 rats. Environ Mol Mutagen. 56(7):621–628.
  • Trouiller B, Reliene R, Westbrook A, Solaimani P, Schiestl RH. 2009. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 69(22):8784–8789.
  • U.S. EPA. 1991. National primary drinking water regulations-synthetic organic chemicals and inorganic chemicals; monitoring for unregulated contaminants; national primary drinking water regulations implementation; national secondary drinking water regulations. Final rule. Fed Regist. 56:3526–3597.
  • U.S. EPA. 2005. Guidelines for carcinogen risk assessment, EPA/630/P-03/001F. Risk Assessment Forum: US Environmental Protection Agency, Washington, DC.
  • U.S. EPA. 2007. Framework for Determining a Mutagenic Mode of Action for Carcinogenicity: Using EPA’s 2005 Cancer Guidelines and Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens. US Environmental Protection Agency, Washinton, DC. (EPA 120/R-07/002-A).
  • U.S. EPA. 2010. Toxicological review of hexavalent chromium in support of summary information on the integrated risk information system (IRIS). External Review DRAFT. US Environmental Protection Agency, Washington, DC.
  • U.S. EPA. 2017. Data Summary of The Third Unregulated Contaminant Monitoring Rule (UCMR3). EPA 815-S-17-001.(Data accessed on January 15, 2017).
  • Ueno S, Kashimoto T, Susa N, Furukawa Y, Ishii M, Yokoi K, Yasuno M, Sasaki YF, Ueda J, Nishimura Y, et al. 2001. Detection of dichromate (VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs. Toxicol Appl Pharmacol. 170(1):56–62.
  • Wang XF, Xing ML, Shen Y, Zhu X, Xu LH. 2006. Oral administration of Cr(VI) induced oxidative stress, DNA damage and apoptotic cell death in mice. Toxicology. 228(1):16–23. eng.
  • WHO. 2019. Chromium in Drinking Water: Draft Background Document for Development of WHO Guidelines for Drinking-water quality.
  • Wise SS, Wise JP. Sr. 2012. Chromium and genomic stability [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Mutat Res. 733(1-2):78–82.
  • Wronska-Nofer T, Wisniewska-Knypl J, Dziubaltowska E, Wyszynska K. 1999. Prooxidative and genotoxic effect of transition metals (cadmium, nickel,.chromium, and vanadium) in mice. Trace Elem Electrolytes. 16(2):87–92.
  • Young RR, Thompson CM, Dinesdurage HR, Elbekai RH, Suh M, Rohr AC, Proctor DM. 2015. A robust method for assessing chemically induced mutagenic effects in the oral cavity of transgenic Big Blue® rats. Environ Mol Mutagen. 56(7):629–636.
  • Zeller A, Pfuhler S, Albertini S, Bringezu F, Czich A, Dietz Y, Fautz R, Hewitt NJ, Kirst A, Kasper P. 2018. A critical appraisal of the sensitivity of in vivo genotoxicity assays in detecting human carcinogens. Mutagenesis. 33(2):179–193.
  • Zhitkovich A. 2011. Chromium in drinking water: sources, metabolism, and cancer risks [Research Support, N.I.H., Extramural. Chem Res Toxicol. 24(10):1617–1629].